Hyalin Perivascular Arcs and Rings in Sclerosing Atypical Fibroxanthomas
To the Editors: Several variants of atypical fibroxanthoma (AFX) are split based on cytomorphology, for example, clear cell, granular cell, and spindle cell nonpleomorphic types. 1 Nine cases of an unusual variant of AFX with keloidal tumoral sclerosis were presented by Kim and McNiff, 2 following in from an anecdotal report 3 and series of ''keloidal'' AFX. In several cases, ''the keloidal collagen also formed ring-shaped structures surrounding CD31-positive vascular structures.'' This report conveys our research on the perivascular sclerosis in a subset of 10 AFX examples with collagenous arcs and rings (Table 1) .
This curious arc and ring pattern of hyalinized collagen in some AFXs is morphologically similar to the always superficially located perivascular linear and tubular sclerosis in a minority of dermatofibromas. It is cautioned that the keloidal collagen associated with atypical fibrohistiocytic cells in AFX may erroneously lead to the diagnosis of ''keloidal dermatofibroma. 4 '' Interesting in this regard, it has been said that the spectrum of fibrous histiocytoma (a diagnostic term utilized as a synonym for dermatofibroma) can be viewed somewhat more broadly, with dermatofibroma (DF) at one pole and with its ''malignant analogue'' AFX at the other. 5 In both entities, AFX and DF, a sparse central component of CD31positive cells in the sclerotic arcs and rings deemed endothelial cells led to our initial hypothesis that the ''keloidal collagen'' is actually vascular basement membrane material of effete capillaries. Laminins, nidogens, and perlecans are arranged into highly organized supramolecular architectures by vascular basement membranes. 6 We proposed the adherence of these elements likely explained the homogeneous (hyalinized) appearance of this material by obscuring its fibrillar texture (Figs. 1, 2). However, reactions for collagen type IV (specific for vascular basement membrane material) 7 were negative for the morphologically similar curvilinear and circular material in both our AFX and DF examples. Also unreactive were the coarsehyalinized collagen bands ofa common keloid, which like dermal collagen, are predominantly collagen type I. 8 Pericytes are actin-positive cells situated in the basement membranes outside the endothelium of capillaries and venules. During the onset of angiogenesis the intramural pericytes leave the microvascular wall and enter the perivascular space, where they become collagen producing stromal cells. Sundberg et al 9 identified 4 stages of pericyte migration/ progression from the endothelium to a collagen-synthesizing fibroblast in the interstitium. Pericytes have been identified in the wound-healing process via their expression of platelet-derived growth factor, a moiety which enhances neoformation of collagen and is associated with a collagen-rich dense tumor stroma, and have been shown to differentiate into collagenproducing cells during liver fibrosis. 10 Double immunohistochemical reactions in our AFXs and DFs alike display concentric pattern: luminal CD31-positive endothelial cells within a ring of actinpositive pericytes that face the external rim of sclerotic material (Figs. 1C, 2B). Lesional cells of both DF and AFX show no consistent propensity to border the sclerotic material, discounting any role they might have in producing it. This leaves the pericyte stimulated to differentiate into fibroblasts when in a proliferative ''fibrohistiocytic'' environment, as the sole architect because it is consistently found within the rings as expected. Sclerotic hyalin rings similar to the material under discussion have been illustrated in hemangiopericytomas. 10 The consistent localization of the pericyte to within the hyalin rings of the 10 sclerosing AFXs in this series supports the hypothesis that this material is synthesized by pericytes, a proposition that should be tested by more sophisticated studies. (3700) . B, A dual immunohistochemical reaction labels central endothelial cells red for CD31 although actin-positive pericytes are decorated brown as they layer against the external sclerotic ring (3700). C, A collagen IV reaction labels a thin endothelial basement membrane brown that lies between the endothelial cells and pericytes; the thick sclerotic collagenous rind around the vessel is nonreactive, that is, not thickened endothelial basement membrane (31000). 
Expression

Patterns of the Immunosuppressive Proteins PD-1/CD279 and PD-L1/CD274 at Different Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
To the Editors: Programmed death-1 (PD-1/CD279) cell-surface protein, an inhibitory member of the CD28 costimulatory receptor superfamily, is expressed mainly on a subset of activated T lymphocytes including helper T cells located in the follicle germinal centers. 1,2 PD-1 inhibits T-cell activity 3 by providing a second signal to T cells in conjunction with signaling through the T-cell receptor for antigen. Two cell-membrane proteins designated PD-L1 (B7-H1CD274) and PD-L2 (B7-DC/CD273) have been identified as ligands for PD-1. 4, 5 Interactions between PD-1 and the ligands control the induction and maintenance of peripheral T-cell tolerance during normal immune responses. These interactions may play a role also in immune evasion in malignancy 6-8 because PD-1 expression tends to be upregulated on tumor infiltrating lymphocytes 9 and cancer cells of various types aberrantly express PD-L1. 6 In this report, we present results of the immunohistochemical examination of the PD-1 and PD-L1 expression at the patch/plaque, tumor, and large cell transformation stages of cutaneous T-cell lymphoma (CTCL). CTCL cases for the study were retrieved from the Departments of Pathology and Laboratory Medicine and Dermatopathology at the University of Pennsylvania. The diagnosis of different stages of CTCL was established based on the clinical presentation and histologic and immunohistochemical evaluation. To perform the PD-1 and PD-L1 stains, the formalinfixed paraffin-embedded CTCL tissue specimen slides were heat treated for antigen retrieval by boiling in 10 mM citrate buffer pH 6 for 20 minutes. The sections were blocked with the peroxidase blocking system (Dako, Carpinteria, CA) for 10 minutes and 2% normal horse serum for 20 minutes at room temperature. To detect PD1 expression, the slides were incubated with the primary PD-1 mouse monoclonal antibody (Abcam, Cambridge, MA) at 1:200 dilution (overnight at 4(C); secondary biotinylated antimouse antibody at 1:250 dilution (30 minutes at room temperature); the streptavidin-biotinylated horseradish peroxidase complex reagent (Dako) (30 minutes at room temperature); and three 5-minute washes in buffer after each incubations. To detect the PD-L1 expression, the slides were incubated at room temperature with the rabbit PD-L1 antibody (Lifespan Biosciences, Seattle, WA) at 1:200 dilution for 30 minutes and an antirabbit-Horseradish peroxidase polymer for 30 minutes followed by washes. The PD-1 antibody or PD-L1 antibody-stained slides were exposed to the Diaminobenzidine plus chromagen (Dako) for 5 minutes at room temperature and counterstained with hematoxylin. The results of this evaluation are summarized in Table 1 , and the representative images are presented in Fig. 1 . The retrieved 26 specimens were classified as 9 patch/plaque, 6 tumor, and 9 large cell transformation stage lesions.
PD-1 was frequently expressed at the early patch and plaque stages of CTCL ( Fig. 1 , upper panel in the middle column). PD-1 was detected in all 9 patch and plaque cases; in 7 of the 9 cases, more than 25% of the atypical lymphocytes expressed PD-1 including 3 with staining was present 
